MADRIGAL PHARMACEUTICALS, INC.

By person

17 insiders · 204 transactions

117×

Bill Sibold holds 117 times base salary in stock. $108.04M of shares against $918.53K in salary for 2025.

Salary from the company's own proxy. The shares are what Bill Sibold last reported holding, valued at $546.38, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

FRIEDMAN PAUL A

Director

—

$26.66M (38) scheduled

−$26.66M

187,164

0.8101%

$102.26M

+0.4%

Taub Rebecca

Director

—

$21.68M (42) scheduled

−$21.68M

452,667

1.96%

$247.33M

−1.4%

Sibold William John

President and CEO

—

$10.48M (37) scheduled

−$10.48M

197,746

0.8559%

$108.04M

+253.8%

BATE KENNETH

Director

—

$8.03M (11) scheduled

−$8.03M

2,627

0.0114%

$1.44M

+37.4%

Levy Richard S

Director

—

$7.36M (26) scheduled

−$7.36M

22,469

0.0973%

$12.28M

+104.0%

Dier Mardi

EVP and CFO

—

$3.77M (28) scheduled

−$3.77M

12,490

0.0541%

$6.82M

+40.7%

Huntsman Carole

Chief Commercial Officer

—

$1.71M (14) scheduled

−$1.71M

12,692

0.0549%

$6.93M

+10.6%

Soergel David

Chief Medical Officer

—

$951.98K (2) scheduled

−$951.98K

10,033

0.0434%

$5.48M

—

Kelley Shannon T

General Counsel

—

$841.61K (4)

−$841.61K

11,474

0.0497%

$6.27M

+43.7%

BAKER BROS. ADVISORS LP entity

Director

—

1,948,876

8.44%

$1.06B

+9.6%

CRAVES FRED B

Director

—

361,076

1.56%

$197.28M

−1.9%

Waltermire Robert E.

Senior VP, Chief Pharma Dev.

—

5,789

0.0251%

$3.16M

+5.3%

Daly James M

Director

—

3,081

0.0133%

$1.68M

+61.1%

Thakkar Rita

Chief Accounting Officer

—

2,398

0.0104%

$1.31M

—

FOUSE JACQUALYN A

Director

—

1,551

0.0067%

$847.43K

—

Brennan Daniel J.

Director

—

1,371

0.0059%

$749.08K

—

REED JOHN C

Director

—

647

0.0028%

$353.51K

—

MADRIGAL PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out